Page last updated: 2024-10-27
flecainide and Gelineau Syndrome
flecainide has been researched along with Gelineau Syndrome in 1 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Research Excerpts
Excerpt | Relevance | Reference |
"Modafinil is a non-amphetaminic wake-promoting compound used as therapy against sleepiness and narcolepsy." | 3.83 | Impact of Astroglial Connexins on Modafinil Pharmacological Properties. ( Charvériat, M; Chauveau, F; Dauvilliers, Y; Duchêne, A; Giaume, C; Jeanson, T; Lagarde, D; Lin, JS; Liu, X; Mouthon, F; Perier, M; Picoli, C; Piérard, C; Thomasson, J; Zhao, Y, 2016) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Duchêne, A | 1 |
Perier, M | 1 |
Zhao, Y | 1 |
Liu, X | 1 |
Thomasson, J | 1 |
Chauveau, F | 1 |
Piérard, C | 1 |
Lagarde, D | 1 |
Picoli, C | 1 |
Jeanson, T | 1 |
Mouthon, F | 1 |
Dauvilliers, Y | 1 |
Giaume, C | 1 |
Lin, JS | 1 |
Charvériat, M | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Therapeutic Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation in Healthy Subjects[NCT03182413] | Phase 1 | 20 participants (Actual) | Interventional | 2015-09-30 | Completed |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for flecainide and Gelineau Syndrome